SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation

OBJECTIVES: Humoral and cellular immunity to SARS‐CoV‐2 following COVID‐19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS‐CoV‐2 amidst the ongoing pandemic. METHODS: Here,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Transl Immunology
Hauptverfasser: Sandberg, John Tyler, Varnaitė, Renata, Christ, Wanda, Chen, Puran, Muvva, Jagadeeswara R, Maleki, Kimia T, García, Marina, Dzidic, Majda, Folkesson, Elin, Skagerberg, Magdalena, Ahlén, Gustaf, Frelin, Lars, Sällberg, Matti, Eriksson, Lars I, Rooyackers, Olav, Sönnerborg, Anders, Buggert, Marcus, Björkström, Niklas K, Aleman, Soo, Strålin, Kristoffer, Klingström, Jonas, Ljunggren, Hans‐Gustaf, Blom, Kim, Gredmark‐Russ, Sara
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2021
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8256672/
https://ncbi.nlm.nih.gov/pubmed/34257967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1306
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge